0001181431-13-041158.txt : 20130723
0001181431-13-041158.hdr.sgml : 20130723
20130723190909
ACCESSION NUMBER: 0001181431-13-041158
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130723
FILED AS OF DATE: 20130723
DATE AS OF CHANGE: 20130723
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROOT JONATHAN D
CENTRAL INDEX KEY: 0001225480
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 13982225
MAIL ADDRESS:
STREET 1: 2735 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
rrd385949.xml
X0306
4
2013-07-23
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001225480
ROOT JONATHAN D
2735 SAND HILL ROAD
MENLO PARK
CA
94025
1
0
1
0
Common Stock
2013-07-23
4
C
0
1028381
A
1028381
I
Directly owned by USVP VIII
Common Stock
2013-07-23
4
C
0
1215407
A
2243788
I
Directly owned by USVP VIII
Common Stock
2013-07-23
4
C
0
1505032
A
3748820
I
Directly owned by USVP VIII
Common Stock
2013-07-23
4
P
0
155164
17.00
A
3903984
I
Directly owned by USVP VIII
Common Stock
2013-07-23
4
C
0
9505
A
9505
I
Directly owned by EP VIII-A
Common Stock
2013-07-23
4
C
0
11233
A
20738
I
Directly owned by EP VIII-A
Common Stock
2013-07-23
4
C
0
13910
A
34648
I
Directly owned by EP VIII-A
Common Stock
2013-07-23
4
P
0
1434
17.00
A
36082
I
Directly owned by EP VIII-A
Common Stock
2013-07-23
4
C
0
4817
A
4817
I
Directly owned by EP VIII-B
Common Stock
2013-07-23
4
C
0
5694
A
10511
I
Directly owned by EP VIII-B
Common Stock
2013-07-23
4
C
0
7051
A
17562
I
Directly owned by EP VIII-B
Common Stock
2013-07-23
4
P
0
727
17.00
A
18289
I
Directly owned by EP VIII-B
Common Stock
2013-07-23
4
C
0
9926
A
9926
I
Directly owned by AFF VIII
Common Stock
2013-07-23
4
C
0
11731
A
21657
I
Directly owned by AFF VIII
Common Stock
2013-07-23
4
C
0
14527
A
36184
I
Directly owned by AFF VIII
Common Stock
2013-07-23
4
P
0
1498
17.00
A
37682
I
Directly owned by AFF VIII
Series A Preferred Stock
2013-07-23
4
C
0
1028381
D
Common Stock
1028381
0
I
Directly owned by USVP VIII
Series A Preferred Stock
2013-07-23
4
C
0
9505
D
Common Stock
9505
0
I
Directly owned by EP VIII-A
Series A Preferred Stock
2013-07-23
4
C
0
4817
D
Common Stock
4817
0
I
Directly owned by EP VIII-B
Series A Preferred Stock
2013-07-23
4
C
0
9926
D
Common Stock
9926
0
I
Directly owned by AFF VIII
Series B Preferred Stock
2013-07-23
4
C
0
1215407
D
Common Stock
1215407
0
I
Directly owned by USVP VIII
Series B Preferred Stock
2013-07-23
4
C
0
11233
D
Common Stock
11233
0
I
Directly owned by EP VIII-A
Series B Preferred Stock
2013-07-23
4
C
0
5694
D
Common Stock
5694
0
I
Directly owned by EP VIII-B
Series B Preferred Stock
2013-07-23
4
C
0
11731
D
Common Stock
11731
0
I
Directly owned by AFF VIII
Series B-1 Preferred Stock
2013-07-23
4
C
0
1505032
D
Common Stock
1505032
0
I
Directly owned by USVP VIII
Series B-1 Preferred Stock
2013-07-23
4
C
0
13910
D
Common Stock
13910
0
I
Directly owned by EP VIII-A
Series B-1 Preferred Stock
2013-07-23
4
C
0
7051
D
Common Stock
7051
0
I
Directly owned by EP VIII-B
Series B-1 Preferred Stock
2013-07-23
4
C
0
14527
D
Common Stock
14527
0
I
Directly owned by AFF VIII
Each share of Series A, Series B and Series B-1 Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering on July 23, 2013.
The reported securities are owned directly by each of U.S. Venture Partners VIII, L.P. ("USVP VIII"), USVP VIII Affiliates Fund, L.P. ("AFF VIII"), USVP Entrepreneur Partners VIII-A, L.P. ("EP VIII-A") and USVP Entrepreneur Partners VIII-B, L.P. ("EP VIII-B" and together with USVP VIII, AFF VIII and EP VIII-A, the "USVP Funds"). Presidio Management Group VIII, LLC, or PMG VIII, is the general partner of the USVP Funds, and may be deemed to have sole voting and dispositive power over the shares held by the USVP Funds. PMG VIII and Irwin Federman, Winston Fu, Steven Krausz, David Liddle, Jonathan Root, Christopher Rust, Casey Tansey and Philip Young, the managing members of PMG VII, who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the USVP Funds except to the extent of any pecuniary interest therein.
The securities are immediately convertible.
The expiration date is not relevant to the conversion of these securities.
/s/ Yvonne Li, Attorney-in-Fact for Jonathan D. Root
2013-07-23